(Q36838782)

16 August 2017

1 reference

title

Update in chronic obstructive pulmonary disease 2006. (English)

1 reference

chronic obstructive pulmonary disease

16 August 2017

1 reference

Klaus F Rabe

1

1 reference

16 August 2017

Bianca Beghé

series ordinal

2

1 reference

16 August 2017

Fabrizio Luppi

series ordinal

3

1 reference

16 August 2017

Leonardo M Fabbri

series ordinal

4

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

American Journal of Respiratory and Critical Care Medicine

16 August 2017

1 reference

16 August 2017

175

1 reference

16 August 2017

1222-1232

1 reference

16 August 2017

12

1 reference

Update in chronic obstructive pulmonary disease 2005.

16 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Proposal for a multidimensional staging system for chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Mortality in COPD: Role of comorbidities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Patterns of comorbidities in newly diagnosed COPD and asthma in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Post-bronchodilator spirometry reference values in adults and implications for disease management

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Case definitions for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Variability of spirometry in chronic obstructive pulmonary disease: results from two clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Global burden of COPD: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Epidemiology and costs of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Predictors of mortality in patients with emphysema and severe airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

The selective advantage of alpha1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), France

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

MUC7 haplotype analysis: results from a longitudinal birth cohort support protective effect of the MUC7*5 allele on respiratory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Decorin and TGF-beta1 polymorphisms and development of COPD in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Beta2-adrenergic receptor polymorphisms are associated with asthma and COPD in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Genetic association analysis of functional impairment in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Cigarette smoke-induced Egr-1 upregulates proinflammatory cytokines in pulmonary epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

The SERPINE2 gene is associated with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Inflammatory cells in the airways in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Thomas a. Neff lecture. Chronic obstructive pulmonary disease: a systemic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Differences in local versus systemic TNFalpha production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNFalpha release

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Altered T-cell phenotypes in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Matrix regulation of lung injury, inflammation, and repair: the role of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Role of TNFalpha in pulmonary pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Targeting the networks that underpin contiguous immunity in asthma and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Chronic obstructive pulmonary disease: histopathology, inflammation and potential therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Neutrophil migration through preexisting holes in the basal laminae of alveolar capillaries and epithelium during streptococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Alteration of fibroblast architecture and loss of Basal lamina apertures in human emphysematous lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Prescription of oxygen: still problems after all these years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Oxidative stress and redox regulation of lung inflammation in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Superoxide dismutase expression attenuates cigarette smoke- or elastase-generated emphysema in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Role of lung maintenance program in the heterogeneity of lung destruction in emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Oxidants and signaling by mitogen-activated protein kinases in lung epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Transcription factors in airway diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Adenosine signaling in asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Identifying and hurdling obstacles to translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Activated oligoclonal CD4+ T cells in the lungs of patients with severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Cigarette smoke-induced emphysema: A role for the B cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Antielastin autoimmunity in tobacco smoking-induced emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Treatment with AM3 restores defective T-cell function in COPD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Pulmonary dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

C-reactive protein in patients with COPD, control smokers and non-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Genetic determinants of C-reactive protein in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Raised CRP levels mark metabolic and functional impairment in advanced COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Hyperinflation, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Skeletal muscles in chronic obstructive pulmonary disease: deconditioning, or myopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Titin and diaphragm dysfunction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

The effect of exercise on peripheral muscle in emphysema: a preliminary investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Quantitative computed tomography of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

New concepts in the radiological assessment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

State of the art. Bronchiolitis in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Computed tomographic imaging of the airways: relationship to structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Airflow limitation and airway dimensions in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Early emphysematous changes in asymptomatic smokers: detection with 3He MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

COPD exacerbations .1: Epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

How viral infections cause exacerbation of airway diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Role of viral infections in asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Pathophysiology of exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Risk factors of frequent exacerbations in difficult-to-treat asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Pulmonary biomarkers in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Brain natriuretic peptide is a prognostic parameter in chronic lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Markers of disease severity in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Markers of exacerbation severity in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Chronic obstructive pulmonary disease exacerbation and risk of pulmonary embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Efficacy of varenicline for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Response to pneumococcal vaccine in chronic obstructive lung disease—The effect of ongoing, systemic steroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Inhibition of reactive nitrogen species production in COPD airways: comparison of inhaled corticosteroid and oral theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Toward therapeutic pulmonary alveolar regeneration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Feasibility of retinoids for the treatment of emphysema study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

First study of infliximab treatment in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Lung transplantation in patients with chronic obstructive pulmonary disease in a national cohort is without obvious survival benefit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Lung transplantation in patients 60 years and older: results, complications, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

A multicenter trial of an intrabronchial valve for treatment of severe emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Outcomes of delayed chest closure after bilateral lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Patient and surgical factors influencing air leak after lung volume reduction surgery: lessons learned from the National Emphysema Treatment Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Lung tissue engineering technique with adipose stromal cells improves surgical outcome for pulmonary emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Bronchoscopic procedures for emphysema treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Pulmonary rehabilitation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Interval versus continuous high-intensity exercise in chronic obstructive pulmonary disease: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

How long should outpatient pulmonary rehabilitation be? A randomised controlled trial of 4 weeks versus 7 weeks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease: a randomized crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Randomised trial of ambulatory oxygen in oxygen-dependent COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Overnight prescription of oxygen in long term oxygen therapy: time to reconsider the guidelines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Long term oxygen therapy adherence and COPD: what we don't know

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Continuous oxygen monitoring--a better way to prescribe long-term oxygen therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Prolonged invasive ventilation following acute ventilatory failure in COPD: weaning results, survival, and the role of noninvasive ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Transtracheal open ventilation in acute respiratory failure secondary to severe chronic obstructive pulmonary disease exacerbation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Cryptic haplotypes ofSERPINA1confer susceptibility to chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Relationship between Extent of Pulmonary Emphysema by High-resolution Computed Tomography and Lung Elastic Recoil in Patients with Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Lung Function Decline and Outcomes in an Adult Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

The Effect of Smoking on the Transcriptional Regulation of Lung Inflammation in Patients with Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Inflammatory Lung Secretions Inhibit Dendritic Cell Maturation and Function via Neutrophil Elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200704-586UP

10.1164/RCCM.200704-586UP

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference